Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Merck_&_Co.
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:CEO |
gptkb:Habib_Dable
|
| gptkbp:developedBy |
protein therapeutics
|
| gptkbp:focusesOn |
pulmonary diseases
rare blood disorders therapeutics for serious and rare diseases |
| gptkbp:foundedYear |
2003
|
| gptkbp:founder |
gptkb:Mark_Ptashne
gptkb:Jasbir_Seehra gptkb:John_Knopf gptkb:Tom_Maniatis |
| gptkbp:fullName |
gptkb:Acceleron_Pharma_Inc.
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Acceleron
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:luspatercept
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:XLRN
|
| gptkbp:website |
https://www.acceleronpharma.com/
|
| gptkbp:bfsParent |
gptkb:Bayer_Crop_Science
|
| gptkbp:bfsLayer |
6
|